1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Mitochondrial complex I deficiency: new trials by email Literature Review of Mitochondrial complex I deficiency trials Research Report on Mitochondrial complex I deficiency
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate Efficacy and Safety of Elamipretide in Subjects With Primary Mitochondrial Disease From Nuclear DNA Mutations (nPMD) Elamipretide, Placebo - Mitochondrial Myopathies, Mitochondrial Pathology | Phase 3 | Completed | Stealth BioTherapeutics Inc. | 102 | 2022-04-29 | 2025-10-24 |
Mitochondrial Diseases (1) · Mitochondrial Myopathies (1) · Muscle Weakness (1) · Ophthalmoplegia, Chronic Progressive External (1)
Chronic Disease (1) · Cranial Nerve Diseases (1) · Disease Attributes (1) · Eye Diseases (1) · Metabolic Diseases (1) · Muscular Diseases (1) · Musculoskeletal Diseases (1) · Nervous System Diseases (1) · Neurologic Manifestations (1) · Neuromuscular Diseases (1) · Neuromuscular Manifestations (1) · Nutritional and Metabolic Diseases (1) · Ocular Motility Disorders (1) · Ophthalmoplegia (1) · Paralysis (1)
arginyl-2,'6'-dimethyltyrosyl-lysyl-phenylalaninamide (1)
Stealth BioTherapeutics Inc. (1)
Australia (1) · Germany (1) · Hungary (1) · Italy (1) · Netherlands (1) · New Zealand (1) · Norway (1) · Spain (1) · United Kingdom (1) · United States (1)